Identification of a Prognostic Signature Based on Tumor‐Infiltrating B Lymphocyte mRNA in Head and Neck Squamous Cell Carcinoma
Journal of Immunology Research · 2025
DOI: 10.1155/jimr/9375885 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Immunology Research, 2025. Verfasst von Mingjun Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Qingdao Medical College, Qingdao University, Qingdao 266000, China. Hauptthemen laut MEDLINE: Lymphocytes, Tumor-Infiltrating, Squamous Cell Carcinoma of Head and Neck, B-Lymphocytes, Head and Neck Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Taishan Scholar Project of Shandong Province.
Abstract (Originalsprache)
Introduction
Tumor‐infiltrating B cells (TILBs) are an important part of the immune response during tumor regulation. However, the significance of B cells in immunotherapy has not been fully determined.
Methods
In this study, highly expressed genes in B cells were obtained by comparing the gene expression in B cells with that in other immune cells and were named TILB‐mRNAs. Among them, those genes expressed in patients with head and neck squamous cell carcinoma (HNSCC) identified in The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) atlas were employed to screen for genes associated with HNSCC prognosis using univariate Cox analysis, least absolute shrinkage and selection operator (LASSO) regression analysis, and a TILB‐related signature was constructed to predict patient prognostic risk using multivariate Cox regression analyses.
Results
The constructed TILB‐related signature, which comprised seven mRNAs ( ZNF439 , KMO , KDM5D , IFT57 , HDAC9 , GSAP , and CCR 7), was verified to have a good ability to predict the prognosis of patients with HNSCC using three independent validation datasets from GEO, and the predictive ability was not affected by other factors. The signature reflected the state of immune cell infiltration in tumor tissue, especially B cells, patients with higher risk scores (RSs) had fewer infiltrating immune cells in their tumors, especially B cells. The gene expression of the TILB‐related signature was also verified in TILBs from HNSCC using single‐cell analysis, revealing that TILB‐related marker genes were differentially expressed in different GB cell subsets.
Discussion
This study provides risk assessment and outcome prediction for patients with HNSCC and provides potential targets for immunotherapy of HNSCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Qingdao Medical College, Qingdao University, Qingdao 266000, China.
- Department of Otorhinolaryngology Head and Neck Surgery, Yantai Yuhuangding Hospital, Yantai 264000, China.
- Shandong Provincial Clinical Research Center for Otorhinolaryngologic Diseases, Yantai Yuhuangding Hospital, Yantai 264000, China.
- Shandong Provincial Key Laboratory of Neuroimmune Interaction and Regulation, Yantai Yuhuangding Hospital, Yantai 264000, China.
- Yantai Key Laboratory of Otorhinolaryngologic Diseases, Yantai Yuhuangding Hospital, Yantai 264000, China.
ORCID-Profile: Mingjun Zhang, Qi Sun, Yisong Yao, Xi Chen, Jiaxuan Li, Ting Yuan, Yakui Mou, Yumei Li, Xicheng Song
Förderung
- Taishan Scholar Project of Shandong Province
Zitieren
APA
Zhang, M., Sun, Q., Yao, Y., Chen, X., Li, J., Yuan, T., Mou, Y., Li, Y., & Song, X. (2025). Identification of a Prognostic Signature Based on Tumor‐Infiltrating B Lymphocyte mRNA in Head and Neck Squamous Cell Carcinoma. Journal of Immunology Research. https://doi.org/10.1155/jimr/9375885
Vancouver
Zhang M, Sun Q, Yao Y, Chen X, Li J, Yuan T, et al. Identification of a Prognostic Signature Based on Tumor‐Infiltrating B Lymphocyte mRNA in Head and Neck Squamous Cell Carcinoma. Journal of Immunology Research. 2025. doi:10.1155/jimr/9375885
BibTeX
@article{Zhang2025,
author = {Zhang, Mingjun and Sun, Qi and Yao, Yisong and Chen, Xi and Li, Jiaxuan and Yuan, Ting and Mou, Yakui and Li, Yumei and Song, Xicheng},
title = {Identification of a Prognostic Signature Based on Tumor‐Infiltrating B Lymphocyte mRNA in Head and Neck Squamous Cell Carcinoma},
journal = {Journal of Immunology Research},
year = {2025},
doi = {10.1155/jimr/9375885}
}
EUVIMED